Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
- Status
- RECRUITING
- Phase
- PHASE2
Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Botensilimab and Balstilimab Optimization in Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2